PV Papers

Tweeting articles in the field of pharmacovigilance.
Moving to Linked In:

[PV Papers @PVpapers]

Hello, this channel will go silent on October 3rd.
The flow of papers will continue on LinkedIn: https://t.co/2Vwmk5cGZb

[PV Papers @PVpapers]

Today is the start of #medsafetyweek

A Multidisciplinary Approach in Pharmacovigilance Awareness: ISoP Egypt Chapter’s MedSafetyWeek Experience
https://t.co/Uj25hFjLEw

[PV Papers @PVpapers]

Anaphylaxis due to antiallergic and antiasthmatic biologics
https://t.co/EOZlliXoyF

[PV Papers @PVpapers]

Drug-induced Sweet’s syndrome: a case/non-case study in the French pharmacovigilance database
https://t.co/ApDH1tzpSX

[PV Papers @PVpapers]

Lower Urinary Tract Disorders as Adverse Drug Reactions—A Literature Review
https://t.co/POhcgOjOML

[PV Papers @PVpapers]

Costs associated with adverse drug reactions in an older population admitted to hospital: A prospective cohort study
https://t.co/M4VwWpPMgb

[PV Papers @PVpapers]

Predictive modeling of adverse drug reactions to tamoxifen therapy for breast cancer on base of pharmacogenomic testing
https://t.co/zB7OZm6rr5

[PV Papers @PVpapers]

Disproportionality Analysis of Lenvatinib-Caused Gastrointestinal Perforation in Cancer Patients: A Pharmacovigilance Analysis Based on the US Food and Drug Administration Adverse Event Reporting System.
https://t.co/POhcgOjgXd

[PV Papers @PVpapers]

Bleeding risk with concurrent use of anticoagulants and ibrutinib: A population-based nested case-control study
https://t.co/kCTJSUtkje

[PV Papers @PVpapers]

PDF: Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries
https://t.co/t3ZvBDmrpo

[PV Papers @PVpapers]

PDF: Why pharmacovigilance of traditional medicines used as analgesics is important?
https://t.co/O2BFGJqMga

[PV Papers @PVpapers]

Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study
https://t.co/5HYrLYrosA

[PV Papers @PVpapers]

Crucial need for improved pharmacovigilance in pregnancy
https://t.co/PvPV7lukeN

[PV Papers @PVpapers]

Drug related hypophosphatemia: Descriptive study and case/no-case analysis of the French national pharmacovigilance database
https://t.co/wmKXbq0Bj5

[PV Papers @PVpapers]

Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system
https://t.co/rLURRtO1nW

[PV Papers @PVpapers]

Gender differences in adverse events related to Osimertinib: a real-world pharmacovigilance analysis of FDA adverse event reporting system
https://t.co/DmhFLeKqY5

[PV Papers @PVpapers]

Warfarin and Antibiotics: Drug Interactions and Clinical Considerations
https://t.co/Caxy7ox6od

[PV Papers @PVpapers]

The pharmacogenomics of carbamazepine-induced cutaneous adverse drug reaction in the South of Vietnam
https://t.co/usABGsEw8p

[PV Papers @PVpapers]

A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
https://t.co/7Na9XWYjJQ

[PV Papers @PVpapers]

A Pharmacovigilance Study on the Safety of Axicabtagene Ciloleucel Based on Spontaneous Reports from the EudraVigilance Database
https://t.co/YLT8I1Ox5N